-
1 week ago | 
pulmonaryfibrosisnews.com | Ann Reynoso |Lindsey Shapiro |Marisa Wexler |Samuel Kirton
I recently underwent a bronchoscopy and bronchoalveolar lavage. While I was confident that I was under the care of competent professionals and trusted that the procedure would be conducted efficiently, I experienced a brief moment of apprehension and unease just before it. A bronchoscopy allows doctors to view your airways using a thin, lighted tube. During a bronchoalveolar lavage, a small amount of saline is inserted into the tube to wash the airways.
-
3 weeks ago | 
pulmonaryfibrosisnews.com | Samuel Kirton |Patricia Inacio |Marisa Wexler |Steve Bryson
One of the lessons idiopathic pulmonary fibrosis (IPF) has taught me is that not everything will go as planned. For that reason, this past weekend we celebrated Halloween and One-Half (which we call HH). Flexibility is important to everyone on this journey. Let me explain. Before my IPF diagnosis, my wife, Susan, and I used to throw a big Halloween party each year.
-
4 weeks ago | 
pulmonaryfibrosisnews.com | Marisa Wexler |Steve Bryson |Samuel Kirton |Andrea Lobo
Basal stem cells taken from the upper part of a patient’s respiratory tract can be expanded in the lab and then transplanted back into their lungs to treat idiopathic pulmonary fibrosis (IPF), according to a recent study. “Our clinical observations herein show that [basal cells] infusion is able to further prevent deterioration and reverse the declining trend of lung function parameters,” scientists wrote.
-
1 month ago | 
pulmonaryfibrosisnews.com | Samuel Kirton |Patricia Inacio |Ann Reynoso
It was five years ago this month that COVID-19 was beginning to consume the headlines. Around the world, those headlines provided an early view of what a pandemic might look like here in the U.S. In fact, five years ago school systems here began shutting down because of the threat. We learned a lot from that crisis. So who had a growing measles outbreak on their bingo card for 2025? More about that in a minute.
-
1 month ago | 
pulmonaryfibrosisnews.com | Samuel Kirton |Marisa Wexler |Charlene Marshall
Fraternal organizations have long been a part of colleges and universities. It’s not uncommon to find an area around campus labeled as Greek Row. These organizations allow like-minded individuals to join together, taking hold even beyond college campuses. When I was diagnosed with idiopathic pulmonary fibrosis (IPF) in early 2017, I had no idea I was joining a fraternity — one that no one wants to be a part of.
-
2 months ago | 
pulmonaryfibrosisnews.com | Samuel Kirton |Steve Bryson |Ann Reynoso |Charlene Marshall
Have you seen the T-shirt or sign that reads “Keep Calm and Carry On” (KCCO)? You might be surprised to learn the story behind this phrase. Created in 1939, it was part of a three-poster series intended to boost morale during World War II. Ironically, the Keep Calm and Carry On poster was never published or made public. It might have faded away were it not discovered in a box at a book auction in 2000.
-
2 months ago | 
pulmonaryfibrosisnews.com | Patricia Inacio |Steve Bryson |Samuel Kirton
Low total cholesterol levels are linked to a higher risk of death among people with idiopathic pulmonary fibrosis, a new study from China with more than three years of follow-up data found. “We conducted a long-term follow-up study in patients with IPF and observed that lower [total cholesterol] levels were associated with [an] increased risk of mortality,” the researchers wrote.
-
2 months ago | 
pulmonaryfibrosisnews.com | Samuel Kirton |Steve Bryson |Charlene Marshall
We’re not all the same. When I share details about my journey with idiopathic pulmonary fibrosis (IPF), I don’t want to give the impression that I’m setting a standard. My goal in writing this column is to share my experiences, which may or may not be similar to others. When Steven Nathan, MD, diagnosed me with IPF in January 2017, it was the culmination of a process that began during my annual physical in October 2016.
-
2 months ago | 
pulmonaryfibrosisnews.com | Steve Bryson |Samuel Kirton |Lindsey Shapiro |Mary Chapman
An imbalance in gene activity within two types of immune cells explains why idiopathic pulmonary fibrosis (IPF) progresses but in people who develop lung fibrosis after a severe COVID-19 infection, their lungs get better, a new study finds. Researchers showed mortality risk in IPF and COVID-19 was tied to the increased activity of seven genes in immune monocytes and decreased activity of 43 genes in immune T-cells.
-
Jan 24, 2025 | 
pulmonaryfibrosisnews.com | Marisa Wexler |Steve Bryson |Andrea Lobo |Samuel Kirton
Mediar Therapeutics is planning to launch a Phase 2 clinical trial to test its experimental therapy MTX-463 in people with idiopathic pulmonary fibrosis (IPF). The company has entered into a global licensing agreement with Eli Lilly to advance the development of MTX-463. Mediar will be responsible for conducting the Phase 2 trial.
